A new virtual reality program for rehabilitating patients after an ischemic stroke has been developed by specialists at Tyumen State Medical University in Russia. Using this program together with a ...
Smokeless nicotine products are being seen as a “bridge” to quitting cigarettes for former and current members of the ...
For decades, treatment of peripheral artery disease has focused almost exclusively on restoring blood flow. Now, new research ...
Aplagon doses first patient in phase 2a trial of APAC with peripheral arterial occlusive disease/chronic limb threatening ischemia: Helsinki, Finland Saturday, March 14, 2026, 18: ...
HELSINKI, 12 March 2026 - Aplagon, a clinical stage biotech pioneering a first-in-class treatment for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...
Aplagon has dosed the first patient in its phase 2a HEALING clinical trial evaluating APAC, a first‑in‑class treatment for thrombo‑inflammatory diseases, in people with peripheral arterial occlusive ...
BACKGROUND: Peripheral artery disease (PAD) and its severe form, chronic limb-threatening ischemia (CLTI), significantly impair blood flow to the lower extremities, affecting millions of adults ...
Founded by futurist and entrepreneur Peter H. Diamandis, the annual Abundance360 Summit convenes leading entrepreneurs, and investors, working at the frontiers of biotechnology, artificial ...
Peripheral artery disease affects approximately 236 million persons worldwide and is diagnosed with an ankle–brachial index of less than 0.90. Among older persons, 3.3% of those without peripheral ...
1 Departments of Pediatric and Imaging, Peace Hospital, Assane Seck University, Ziguinchor, Senegal. 2 Departments of Surgery, Regional Center Hospital, Assane Seck University, Ziguinchor, Senegal. 3 ...
Women and Black patients are more likely to suffer life-changing complications from advanced heart and blood vessel procedures, a trio of new studies says. Persistent over-dilation of muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results